Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CDK19 Antibodies:
anti-Mouse (Murine) CDK19 Antibodies:
anti-Rat (Rattus) CDK19 Antibodies:
Go to our pre-filtered search.
Human Polyclonal CDK19 Primary Antibody for ICC, IF - ABIN4296938
Li, Fassl, Chick, Inuzuka, Li, Mansour, Liu, Wang, King, Shaik, Gutierrez, Ordureau, Otto, Kreslavsky, Baitsch, Bury, Meyer, Ke, Mulry, Kluk, Roy, Kim, Zhang, Geng, Zagozdzon, Jenkinson, Gale, Linch et al.: Cyclin C is a haploinsufficient tumour suppressor. ... in Nature cell biology 2014
Show all 3 Pubmed References
Cow (Bovine) Polyclonal CDK19 Primary Antibody for ELISA - ABIN4296936
Malumbres, Harlow, Hunt, Hunter, Lahti, Manning, Morgan, Tsai, Wolgemuth: Cyclin-dependent kinases: a family portrait. in Nature cell biology 2009
The CDK19 may enable metabolic and transcriptional reprogramming through enhancers and chromatin looping.
These findings confirm that UF-linked mutations in MED12 disrupt composite Mediator-associated kinase activity and identify CDK8/19 as prospective therapeutic targets in uterine fibroids.
Genes coregulated by CDK8/19 and NFkappaB include IL8, CXCL1, and CXCL2.
Moreover, it identified CDK19 and CDK8 to be specifically overexpressed during prostate cancer progression, highlighting their potential as novel therapeutic targets in advanced prostate cancer.
High CDK19 expression is associated with osteosarcoma.
On stimulation of TLR9, CDK8/19 positively regulates inflammatory gene transcription in cooperation with NF-kappaB and C/EBPbeta.
Data suggest that, during neurogenesis, Mediator complex cyclin-dependent kinases (CDK8, CDK19) interact directly with PRC2 (polycomb repressive complex 2) subunit EZH2 (enhancer of zeste homolog 2), as well as SUZ12 (suppressor of zeste 12 homolog).
Mediator-associated kinases CDK8 and CDK19 restrain increased activation of key super-enhancer-associated genes in acute myeloid leukaemia (AML) cells
Microarrays identified target genes for each CDK, and we selected six genes: two target genes of CDK8, two target genes of CDK19 and two genes that were targets for both.
CDK8 and CDK19, individually interact with PRMT5 and WDR77, and their interactions with PRMT5 cause transcriptional repression of C/EBPbeta target genes.
plays a role in mechanisms of transcriptional regulation upon protein phosphorylation. (review)
This gene encodes a protein that is one of the components of the Mediator coactivator complex. The Mediator complex is a multiprotein complex required for transcriptional activation by DNA binding transcription factors of genes transcribed by RNA polymerase II. The protein encoded by this gene is similar to cyclin-dependent kinase 8 which can also be a component of the Mediator complex.
CDC2-related protein kinase 6
, CDK8-like cyclin-dependent kinase
, cell division cycle 2-like 6 (CDK8-like)
, cell division cycle 2-like protein kinase 6
, cell division protein kinase 19
, cyclin dependent kinase 19 variant 2
, cyclin-dependent kinase (CDC2-like) 11
, cyclin-dependent kinase 11
, death-preventing kinase
, cyclin-dependent kinase 8